Loading...
 
Toggle Health Problems and D

The lower the Vitamin D, the worse the COVID-19 (600 in Turkey)– March 2021

A notable key for estimating the severity of COVID-19: 25-hydroxyvitamin D status

Turk J Biochem 2021 DOI: https://doi.org/10.1515/tjb-2020-0423
Image

VitaminDWiki

26 health factors increase the risk of COVID-19 – all are proxies for low vitamin D

COVID-19 treated by Vitamin D - studies, reports, videos

As of Aug 22, 2023, the VitaminDWiki COVID page had:  19 trial results,   37 meta-analyses and reviews,   Mortality studies   see related:   Governments,   HealthProblems,   Hospitals,  Dark Skins,   All 26 COVID risk factors are associated with low Vit D,   Fight COVID-19 with 50K Vit D weekly   Vaccines   Take lots of Vitamin D at first signs of COVID   166 COVID Clinical Trials using Vitamin D (Aug 2023)   Prevent a COVID death: 9 dollars of Vitamin D or 900,000 dollars of vaccine - Aug 2023
5 most-recently changed Virus entries

Id Page Hits Last modification Creator Categories
14127 Diseases treated by high-dose Vitamin D - many studies 1963
24 Sep, 2023 15:39
admin Multiple Sclerosis
Psoriasis
Lupus
Rheumatoid Arthritis
Autoimmune
Top news
Virus
High-Dose
11791 Vitamin D nanoemulsion, with comments on COVID-19 – June 2, 2020 2318
23 Sep, 2023 22:48
admin Forms of Vitamin D
Virus
12596 COVID-19 inflammation extinguished by 60,000 IU of vitamin D nanoemulsion daily for a week – RCT May 2021 4570
23 Sep, 2023 22:45
admin Deficiency of Vitamin D
Intervention
Inflammation
Virus
14687 Mask studies for viral infection: 104 studies: ineffective, 61 studies: harmful - Sept 2023 413
23 Sep, 2023 01:44
admin Virus
14696 Book on COVID and Vitamin D - Sept 2023 76
22 Sep, 2023 15:49
admin Books, videos on Vitamin D
Virus

Virus meta-analyses

 Download the PDF from VitaminDWiki

Background
Vitamin D is recognized to be an immune regulator. Also, it is known to have antiviral effects by several mechanisms, including reducing inflammatory cytokines.

Objectives
To examine the 25-hydroxyvitamin D (25(OH)D) status for assessing the severity of COVID-19.

Methods
This study consisted of 596 patients confirmed as SARS-CoV-2 infection and 59 healthy individuals. The cases separated into non-severe group, severe survival, and severe non-survival group. 25(OH)D and other laboratory parameters were evaluated retrospectively.

Results
In all COVID-19 groups 25(OH)D levels were low compared to controls (p<0.05). 25(OH)D concentrations were lowest in patients in severe non-survival groups than those in other SARS-CoV-2 infection groups (p<0.05). Multivariate regression analysis exhibited that decreasing 25(OH)D was associated with an increased likelihood of non-severe, severe survival and severe non-survival disease. There were significant associations between 25(OH)D and certain inflammatory and hemostatic parameters (p<0.05, for all).

Conclusions
25(OH)D deficiency was observed among patients with COVID-19. Declined steadily 25(OH)D levels make a huge contribution to the scale of the progression of the disease. Correlations support that 25(OH)D may be a substantial tool for utilizing the severity of the disease and estimating the survival. Also, supplementation of 25(OH)D might slow down the course of the COVID-19.


Created by admin. Last Modification: Friday June 25, 2021 14:51:45 GMT-0000 by admin. (Version 5)

Attached files

ID Name Comment Uploaded Size Downloads
15287 Turkey.jpg admin 20 Mar, 2021 01:17 21.80 Kb 29827
15280 COVID Turkey ng.pdf PDF 2021 admin 19 Mar, 2021 23:49 1.59 Mb 251